Promaxo Holdings
Oakland, US · Founded 2024 · Delaware corporation
Find your way into Promaxo Holdings
Sign up to see every warm intro you have to Promaxo Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Promaxo Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MB

Michael BartholomewExecutiveMichael Bartholomew is an executive at Promaxo Holdings with expertise in medical devices and biopharmaceutical product development and commercialization, and experience driving revenue growth and profitability in domestic and international markets.
SV
Srirama VenkataramanExecutive
AV
Amit VohraNamed on SEC filing
Board
DC
Dushyant ChipalkattyBoard director
DH
Derek HenneckeBoard director
Reported raises · per SEC filings
Form D private placements$26.8M disclosed across 1 round · 2026
▶$26.8MraisedMar 2026 · 118 investors · BiotechnologyRule 506(b)
▶$26.8MraisedMar 2026 · 118 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BartholomewExecutive Officer
- Dushyant ChipalkattyDirector
- Srirama VenkataramanExecutive Officer
- Derek HenneckeDirector
- Amit VohraExecutive Officer, Director
- Offering amount
- $28.8M
- Amount sold
- $26.8M
- Minimum investment
- $1
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Promaxo Holdings raised?
- Promaxo Holdings has disclosed $26.8M raised across 1 round.
- Where is Promaxo Holdings headquartered?
- Promaxo Holdings is headquartered in Oakland, US.